Today: 27 January 2026
Subscribe
Browse Category

Biotech Industry News 15 October 2025 - 10 November 2025

Metsera (MTSR) Sinks as Pfizer Seals Revised $10B Buyout; 8‑K Spells Out $65.60 Cash + Up to $20.65 CVR — Nov. 10, 2025

Metsera (MTSR) Sinks as Pfizer Seals Revised $10B Buyout; 8‑K Spells Out $65.60 Cash + Up to $20.65 CVR — Nov. 10, 2025

Shares of Metsera, Inc. (NASDAQ: MTSR) slumped on Monday after the obesity‑drug developer said it will proceed with a sweetened takeover by Pfizer that ends a high‑stakes bidding war with Novo Nordisk. Metsera accepted Pfizer’s revised offer late Friday; Novo dropped out over the weekend. In early U.S. trading today, MTSR fell ~15% as investors recalibrated expectations around the final…
10 November 2025
···
ALPS Group (NASDAQ: ALPS) Stock’s Wild Debut – Biotech Unicorn’s SPAC Merger Sparks Volatile Trading

ALPS Group (NASDAQ: ALPS) Stock’s Wild Debut – Biotech Unicorn’s SPAC Merger Sparks Volatile Trading

Sources: Financial data from Yahoo Finance/Refinitiv Reuters Reuters and company filings; GlobeNewswire press release Globenewswire Globenewswire; Reuters news report Reuters; Bernama (Malaysia) interview with CEO Bernama Bernama; Stock analysis sites and SEC filings for market cap and float details Finviz Stocktitan. All statements and quotes are cited from these sources.…
3 November 2025
··
Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

Novo Nordisk’s $9B Shock Bid Snatches US Weight-Loss Biotech from Pfizer – Stocks React Big

Bidding War Ignites for Obesity Biotech Novo’s takeover push marks a sudden escalation in the weight-loss drug wars. The Danish company – maker of Wegovy and Ozempic – broke ranks on Oct. 30 by notifying Metsera’s board of its superior bid Reuters. This move comes just days after the foundation coup at Novo (demanding faster U.S. growth) Reuters, signaling a…
31 October 2025
···
Thermo Fisher (TMO) Stock Surges on Biotech Boom – Analysts Eye $650 Target

Thermo Fisher (TMO) Stock Surges on Biotech Boom – Analysts Eye $650 Target

Thermo Fisher – the world’s largest life-science tools and services firm – has seen its stock catch fire as investors bet on its growth strategy. Recent weeks’ gains come after a key rally in the biotech sector. For instance, a market report noted TMO’s stock “climb[ed] an impressive 9.79%” on Oct 1 as “market optimism swelled around a series of…
21 October 2025
····
Novo Nordisk’s Surprise $2.1B Rare-Disease Acquisition Deal: What You Need to Know

Novo Nordisk’s Surprise $2.1B Rare-Disease Acquisition Deal: What You Need to Know

Deal Details: Novo Licenses Omeros’s MASP-3 Inhibitor On Oct. 15, Novo Nordisk and Seattle-based Omeros announced a definitive asset purchase and license agreement. Under the terms, Novo gains exclusive global rights to zaltenibart (OMS906) for all indications. Omeros will receive $340 million up front and near-term milestones, plus up to $2.1 billion total with development and sales milestones and tiered royalties…
15 October 2025
···
1 2 3 4

Stock Market Today

  • Soybeans Retreat from Early Gains as Export Data Shows Mixed Signals
    January 27, 2026, 1:25 AM EST. Soybean futures dropped 4 to 5 cents on Monday after initial overnight gains, with March contracts at $10.63 per bushel. The national average cash soybean price rose slightly to $9.93 1/4. Export inspections revealed shipments of 1.324 million metric tons last week, down 1.54% from the week before but up nearly 80% year-on-year. China remained the largest destination. Marketing year shipments have increased 37.5% year-on-year. However, recent export sales are 22% below last year, underperforming USDA projections. Speculative traders reduced net long positions by nearly 3,000 contracts, reflecting cautious sentiment. Brazil's harvest is progressing briskly with a crop estimate raised to 181 million metric tons. Soymeal futures fell $3.90 to $4.70, while soy oil futures inched higher, indicating mixed demand pressures across related commodities.
Go toTop